FOXO1 mRNA downregulation was earlier reported to show a significant association with the lymph node status and age of the patients in prostate cancer cases (Yang et al., 2021), our study also reveals this strong correlation of FOXO1 mRNA expression with these clinical parameters in case of breast cancer patients. This evidence concerns the gene FOXO1 and breast cancer.